<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JHC</journal-id>
<journal-id journal-id-type="hwp">spjhc</journal-id>
<journal-title>Journal of Histochemistry &amp; Cytochemistry</journal-title>
<issn pub-type="ppub">0022-1554</issn>
<issn pub-type="epub">1551-5044</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1369/0022155412440001</article-id>
<article-id pub-id-type="publisher-id">10.1369_0022155412440001</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Microdeletion and Microduplication Syndromes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Weise</surname><given-names>Anja</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Mrasek</surname><given-names>Kristin</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Klein</surname><given-names>Elisabeth</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Mulatinho</surname><given-names>Milene</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Llerena</surname><given-names>Juan C.</given-names><suffix>Jr.</suffix></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Hardekopf</surname><given-names>David</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Pekova</surname><given-names>Sona</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Bhatt</surname><given-names>Samarth</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Kosyakova</surname><given-names>Nadezda</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Liehr</surname><given-names>Thomas</given-names></name>
</contrib>
</contrib-group>
<aff id="aff1-0022155412440001">Jena University Hospital, Friedrich Schiller University, Institute of Human Genetics, Jena, Germany (AW,KM,EK,SB,NK,TL)</aff>
<aff id="aff2-0022155412440001">Instituto Fernandes Figueira, Genetics Department, Rio de Janeiro, Brasil (MM,JCL)</aff>
<aff id="aff3-0022155412440001">Chambon Laboratory for Molecular Diagnostics (member of the Synlab Czech Laboratory Group) Prague, Czech Republic (DH,SP)</aff>
<author-notes>
<corresp id="corresp1-0022155412440001">Anja Weise, Jena University Hospital, Friedrich Schiller University, Institute of Human Genetics, Kollegiengasse 10, 07743 Jena, Germany. Email: <email>Anja.Weise@mti.uni-jena.de</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>60</volume>
<issue>5</issue>
<fpage>346</fpage>
<lpage>358</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>11</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>1</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">The Histochemical Society</copyright-holder>
</permissions>
<abstract>
<p>The widespread use of whole genome analysis based on array comparative genomic hybridization in diagnostics and research has led to a continuously growing number of microdeletion and microduplication syndromes (MMSs) connected to certain phenotypes. These MMSs also include increasing instances in which the critical region can be reciprocally deleted or duplicated. This review catalogues the currently known MMSs and the corresponding critical regions including phenotypic consequences. Besides the pathogenic pathways leading to such rearrangements, the different detection methods and their limitations are discussed. Finally, the databases available for distinguishing between reported benign or pathogenic copy number alterations are highlighted. Overall, a review of MMSs that previously were also denoted “genomic disorders” or “contiguous gene syndromes” is given.</p>
</abstract>
<kwd-group>
<kwd>microdeletion syndrome</kwd>
<kwd>microduplication syndrome</kwd>
<kwd>contiguous gene syndromes</kwd>
<kwd>non-allelic homologues recombination</kwd>
<kwd>array comparative genomic hybridization</kwd>
<kwd>fluorescence in situ hybridization</kwd>
<kwd>multiplex ligation-dependent probe amplification</kwd>
<kwd>quantitative polymerase chain reaction</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Intellectual disability in humans is characterized by significantly impaired cognitive functioning in skills such as communicating, taking care of oneself, and social interactions. Factors such as maternal drug abuse during pregnancy, perinatal oxygen distress, or postnatal infections can be reasons for intellectual disability; however, causative genetic alterations can often be identified. These genetic reasons for intellectual disability in human can be studied by different approaches, related to the assumed underlying genetic defect. Nowadays, banding cytogenetics is still the most widely used initial test in routine diagnostics. If a normal karyotype is observed, further tests may include molecular cytogenetics, to exclude cryptic rearrangements, or molecular genetics. During the past few years an increasing number of so-called contiguous gene syndromes (CGSs) have been identified, mainly in patients with intellectual disability along with a limited number of other syndromes or diseases. CGSs are caused by an aberrant copy number (gain or loss) of a specific subchromosomal region. Originally, CGSs were considered to have critical regions of two or more genes, located in close proximity to each other. Meanwhile, it is known for some of these syndromes that many genes may be involved in the usually duplicated or deleted region, but only one of them is gene-dosage sensitive and causative for the specific clinical signs. Thus, the denomination CGS has been replaced by the designation microdeletion or microduplication syndromes (MMSs).</p>
<sec id="section1-0022155412440001">
<title>Emerging Numbers of MMSs</title>
<p>One model system for MMSs is the Charcot–Marie–Tooth syndrome type 1A (CMT1A) caused by a duplication of the PMP22 gene and its reciprocal microdeletion syndrome hereditary neuropathy with liability to pressure palsies (HNPPs) (<xref ref-type="bibr" rid="bibr18-0022155412440001">Lupski, 1999</xref>). Although before the year 2000 only some dozens of MMSs were known, more and more MMSs have been identified with the availability of new technologies for high-resolution analyses of entire genomes. In particular, the array comparative genomic hybridization (aCGH) technique, which entered the human genome research and diagnostic fields in the end of the last century (<xref ref-type="bibr" rid="bibr22-0022155412440001">Pinkel et al. 1998</xref>), was groundbreaking. The hallmark of aCGH is the identification of submicroscopic gains or losses of euchromatic material, recently called benign or pathogenic copy number variations (CNVs). Although for a pathogenic CNV, correlation with a certain syndrome/phenotype is possible, no such relation is known (yet) for benign CNVs. A pathogenic effect of a CNV is suggested if it is de novo (e.g., <xref ref-type="bibr" rid="bibr1-0022155412440001">Alesi et al. 2011</xref>) or if a specific CNV cannot be found in numerous unrelated healthy individuals studied in parallel (e.g., <xref ref-type="bibr" rid="bibr31-0022155412440001">Willat et al. 2005</xref>).</p>
<p>Meanwhile, the common use of aCGH in research and diagnostics has led to an increase of known benign as well as disease-causing pathogenic CNVs, which is especially reflected in the still-growing numbers of publications. From 1990 to 2011, 200 papers concerning new MMSs were published (<xref ref-type="fig" rid="fig1-0022155412440001">Fig. 1</xref>). Keeping in mind that a common cause for recurrent microdeletions and microduplications is the structure of the human genome, which has countless repeats that can result in non-allelic homologue recombination (NAHR), the expected total number of reciprocal MMSs should be much higher (<xref ref-type="bibr" rid="bibr7-0022155412440001">Gu et al. 2008</xref>). Theoretically, for every microdeletion syndrome there should be a reciprocal microduplication syndrome. However, there are at present 211 microdeletion syndromes versus only 79 microduplication syndromes reported (<xref ref-type="table" rid="table1-0022155412440001">Table 1</xref>, Suppl. Table 1, <xref ref-type="fig" rid="fig2-0022155412440001">Figure 2</xref>). This is a 2.5:1 ratio for a total of 267 different genomic loci with MMSs. Only for 56 of these, loci are reported as reciprocal/colocalizing MMSs, that is, 21%. This is due to several reasons; for instance, meiotic errors leading to duplication and deletion should occur at equal frequencies, but recent studies indicate that early selection during gametogenesis favors either one or the other (<xref ref-type="bibr" rid="bibr27-0022155412440001">Turner et al. 2008</xref>). In fact, it is a general observation that microduplications appear to result in a milder or no clinical phenotype compared with the reciprocal microdeletion. This is even the case on the chromosomal level: trisomies of whole chromosomes or supernumerary marker chromosomes are better tolerated (<xref ref-type="bibr" rid="bibr16-0022155412440001">Liehr et al. 2011</xref>) than are autosomal monosomies.</p>
<fig id="fig1-0022155412440001" position="float">
<label>Figure 1.</label>
<caption>
<p>Growing numbers of publication per year found by searching for the terms <italic>microdeletion syndrome new</italic> and <italic>microduplication syndrome new</italic> in Pub Med (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed">http://www.ncbi.nlm.nih.gov/pubmed</ext-link>).</p>
</caption>
<graphic xlink:href="10.1369_0022155412440001-fig1.tif"/>
</fig>
<table-wrap id="table1-0022155412440001" position="float">
<label>Table 1.</label>
<caption>
<p>All Known Microdeletions and/or Reciprocal Microduplications up to January 2012 by Chromosomes from pter to qter That Are Reported at Least in Two Different Studies or in More Than One Individual</p>
</caption>
<graphic alternate-form-of="table1-0022155412440001" xlink:href="10.1369_0022155412440001-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Microdeletion Syndrome</th>
<th align="center">Microduplication Syndrome</th>
<th align="center">OMIM</th>
<th align="center">Cytoband</th>
<th align="center">Start Position (kb) [hg18]</th>
<th align="center">End Position (kb) [hg18]</th>
</tr>
</thead>
<tbody>
<tr>
<td>microdeletion 1p36</td>
<td align="center">–</td>
<td>607872</td>
<td>1pter-p36.31</td>
<td>0</td>
<td>5.309</td>
</tr>
<tr>
<td>microdeletion 1p36 (GABRD)</td>
<td>microduplication 1p36 (GABRD)</td>
<td>613060</td>
<td>1pter-p36.3</td>
<td>0</td>
<td>10.000</td>
</tr>
<tr>
<td align="center">–</td>
<td>microduplication 1p34.1</td>
<td align="center">–</td>
<td>1p34.1</td>
<td>45.591</td>
<td>46.808</td>
</tr>
<tr>
<td>microdeletion 1p32.2</td>
<td align="center">–</td>
<td>613735</td>
<td>1p32.2</td>
<td>55.500</td>
<td>60.900</td>
</tr>
<tr>
<td>microdeletion 1p21.3</td>
<td align="center">–</td>
<td align="center">–</td>
<td>1p21.3</td>
<td>97.320</td>
<td>99.250</td>
</tr>
<tr>
<td>microdeletion 1q21.1</td>
<td>microduplication 1q21.1</td>
<td>612475</td>
<td>1q21.1</td>
<td>144.980</td>
<td>146.343</td>
</tr>
<tr>
<td>thrombocytopenia-absent radius syndrome/TAR</td>
<td align="center">–</td>
<td>274000</td>
<td>1q21.1</td>
<td>144.150</td>
<td>144.427</td>
</tr>
<tr>
<td>deletion 1q21.1 (GJA5)</td>
<td>duplication 1q21.1 (GJA5)</td>
<td>121013</td>
<td>1q21.1</td>
<td>145.040</td>
<td>145.860</td>
</tr>
<tr>
<td>microdeletion 1q24q25</td>
<td align="center">–</td>
<td align="center">–</td>
<td>1q24.3q25.1</td>
<td>170.135</td>
<td>172.099</td>
</tr>
<tr>
<td>microdeletion 1q24.3</td>
<td align="center">–</td>
<td align="center">–</td>
<td>1q24.3</td>
<td>170.000</td>
<td>170.600</td>
</tr>
<tr>
<td>Van der Waude syndrome/VWS1</td>
<td align="center">–</td>
<td>119300</td>
<td>1q32.2-q41</td>
<td>207.709</td>
<td>208.277</td>
</tr>
<tr>
<td>microdeletion 1q41–42</td>
<td align="center">–</td>
<td>612530</td>
<td>1q41-q42</td>
<td>221.135</td>
<td>221.775</td>
</tr>
<tr>
<td>corpus callosum agenesis microdeletion</td>
<td align="center">–</td>
<td>612337</td>
<td>1q44</td>
<td>242.576</td>
<td>242.936</td>
</tr>
<tr>
<td align="center">–</td>
<td>microduplication 2p25.3</td>
<td align="center">–</td>
<td>2p25.3</td>
<td>3.250</td>
<td>3.450</td>
</tr>
<tr>
<td>Feingold syndrome/FS</td>
<td align="center">–</td>
<td>164280</td>
<td>2p24.3</td>
<td>15.999</td>
<td>16.005</td>
</tr>
<tr>
<td>hypotonia-cystinuria syndrome/HCS</td>
<td align="center">–</td>
<td>606407</td>
<td>2p21</td>
<td>44.384</td>
<td>44.442</td>
</tr>
<tr>
<td>holoprosencephaly 2/HPE2</td>
<td align="center">–</td>
<td>157170</td>
<td>2p21</td>
<td>45.022</td>
<td>45.026</td>
</tr>
<tr>
<td align="center">–</td>
<td>microduplication 2p21</td>
<td align="center">–</td>
<td>2p21</td>
<td>45.200</td>
<td>45.900</td>
</tr>
<tr>
<td>NRXN1 microdeletion</td>
<td>NRXN1 microduplication</td>
<td>600565</td>
<td>2p16.3</td>
<td>50.011</td>
<td>50.437</td>
</tr>
<tr>
<td>microdeletion 2p15–16.1</td>
<td align="center">–</td>
<td>612513</td>
<td>2p15–16.1</td>
<td>57.537</td>
<td>61.534</td>
</tr>
<tr>
<td>microdeletion 2p14-p15</td>
<td align="center">–</td>
<td>612513</td>
<td>2p14–15</td>
<td>63.756</td>
<td>65.377</td>
</tr>
<tr>
<td>microdeletion 2p11.2-p12</td>
<td align="center">–</td>
<td>613564</td>
<td>2p11.2-p12</td>
<td>77.597</td>
<td>87.091</td>
</tr>
<tr>
<td>microdeletion 2q11.2 (LMAN2L, ARID5A)</td>
<td align="center">–</td>
<td align="center">–</td>
<td>2q11.2</td>
<td>96.090</td>
<td>97.040</td>
</tr>
<tr>
<td>mesomelic dysplasia/MMD</td>
<td align="center">–</td>
<td>605274</td>
<td>2q11.2</td>
<td>99.530</td>
<td>100.125</td>
</tr>
<tr>
<td>microdeletion 2q11.2q13 (NCK2, FHL2)</td>
<td>microduplication 2q11.2q13 (NCK2, FHL2)</td>
<td>602633/604930</td>
<td>2q11.2q13</td>
<td>100.060</td>
<td>107.810</td>
</tr>
<tr>
<td>nephronophthisis 1/NPHP1</td>
<td>microduplication 2q11.2q13</td>
<td>256100</td>
<td>2q13</td>
<td>110.293</td>
<td>110.320</td>
</tr>
<tr>
<td>microdeletion 2q13</td>
<td>microduplication 2q13</td>
<td align="center">–</td>
<td>2q13</td>
<td>111.050</td>
<td>112.950</td>
</tr>
<tr>
<td>autism-dyslexia microdeletion 2q14.3</td>
<td>microduplication 2q14.3 (own case)</td>
<td align="center">–</td>
<td>2q14.3</td>
<td>124.500</td>
<td>125.500</td>
</tr>
<tr>
<td>Mowat–Wilson syndrome/MWS</td>
<td align="center">–</td>
<td>235730</td>
<td>2q22.3</td>
<td>144.900</td>
<td>144.994</td>
</tr>
<tr>
<td>microdeletion 2q23.1</td>
<td align="center">–</td>
<td>156200</td>
<td>2q23.1</td>
<td>148.964</td>
<td>149.150</td>
</tr>
<tr>
<td>microdeletion 2q23.3q24.1</td>
<td align="center">–</td>
<td>156200</td>
<td>2q23.3-q24.1</td>
<td>153.150</td>
<td>156.930</td>
</tr>
<tr>
<td>microdeletion 2q24.3</td>
<td>neonatal epilepsy microduplication</td>
<td>607208/604403</td>
<td>2q24.2-q24.3</td>
<td>165.133</td>
<td>166.562</td>
</tr>
<tr>
<td>synpolydactyly 1/SPD1</td>
<td>microduplication 2q31.1</td>
<td>613681</td>
<td>2q31.1</td>
<td>176.659</td>
<td>177.679</td>
</tr>
<tr>
<td>microdeletion 2q31.2-q32.3</td>
<td align="center">–</td>
<td>612345</td>
<td>2q31.2-q32.2</td>
<td>177.640</td>
<td>191.380</td>
</tr>
<tr>
<td>microdeletion 2q33.1</td>
<td align="center">–</td>
<td>612313</td>
<td>2q33.1</td>
<td>196.538</td>
<td>204.915</td>
</tr>
<tr>
<td>brachydactyly-mental retardation syndrome/BDMR</td>
<td align="center">–</td>
<td>600430</td>
<td>2q37</td>
<td>239.620</td>
<td>242.951</td>
</tr>
<tr>
<td>distal 3p deletion</td>
<td align="center">–</td>
<td>613792</td>
<td>3p25-p26</td>
<td>0</td>
<td>6.995</td>
</tr>
<tr>
<td>Von Hippel Lindau disease/VHL</td>
<td align="center">–</td>
<td>193300</td>
<td>3p25-p26</td>
<td>10.158</td>
<td>10.169</td>
</tr>
<tr>
<td>microdeletion 3p21.31</td>
<td align="center">–</td>
<td align="center">–</td>
<td>3p21.31</td>
<td>49.120</td>
<td>52.220</td>
</tr>
<tr>
<td>microdeletion 3p14.1p13</td>
<td align="center">–</td>
<td>605515</td>
<td>3p14.1-p13</td>
<td>71.164</td>
<td>71.959</td>
</tr>
<tr>
<td>microdeletion 3p11.1p12.1</td>
<td align="center">–</td>
<td align="center">–</td>
<td>3p11.2-p12.1</td>
<td>87.069</td>
<td>87.408</td>
</tr>
<tr>
<td>proximal 3q microdeletion syndrome</td>
<td align="center">–</td>
<td align="center">–</td>
<td>3q13.11-q13.12</td>
<td>106.400</td>
<td>108.900</td>
</tr>
<tr>
<td>microdeletion 3q13.31</td>
<td align="center">–</td>
<td align="center">–</td>
<td>3q13.31</td>
<td>115.335</td>
<td>115.916</td>
</tr>
<tr>
<td>blepharophimosis, ptosis, and epicanthus inversus syndrome/BPES</td>
<td align="center">–</td>
<td>110100</td>
<td>3q23</td>
<td>140.146</td>
<td>140.148</td>
</tr>
<tr>
<td>Dandy–Walker syndrome/DWS</td>
<td align="center">–</td>
<td>220200</td>
<td>3q24</td>
<td>148.610</td>
<td>148.617</td>
</tr>
<tr>
<td>microdeletion 3q27.3q29</td>
<td align="center">–</td>
<td align="center">–</td>
<td>3q27.3-q29</td>
<td>188.870</td>
<td>198.080</td>
</tr>
<tr>
<td>microdeletion 3q29</td>
<td>microduplication 3q29</td>
<td>609425/611936</td>
<td>3q29</td>
<td>197.126</td>
<td>198.982</td>
</tr>
<tr>
<td>Wolf–Hirschhorn syndrome/WHS</td>
<td>microduplication 4p16.3</td>
<td>194190</td>
<td>4pter-p16.3</td>
<td>0</td>
<td>2.043</td>
</tr>
<tr>
<td align="center">–</td>
<td>microduplication 4p16.1</td>
<td align="center">–</td>
<td>4p16.1</td>
<td>9.450</td>
<td>10.450</td>
</tr>
<tr>
<td>microdeletion 4p15.3</td>
<td align="center">–</td>
<td align="center">–</td>
<td>4p15.3</td>
<td>16.583</td>
<td>20.747</td>
</tr>
<tr>
<td>microdeletion 4q21.21q21.22</td>
<td align="center">–</td>
<td>613509</td>
<td>4q21.21q21.22</td>
<td>81.950</td>
<td>83.350</td>
</tr>
<tr>
<td>microdeletion 4q21</td>
<td align="center">–</td>
<td>613509</td>
<td>4q21</td>
<td>82.228</td>
<td>83.601</td>
</tr>
<tr>
<td>microdeletion 4q21.2q21.3</td>
<td align="center">–</td>
<td align="center">–</td>
<td>4q21.2-q21.3</td>
<td>89.148</td>
<td>89.218</td>
</tr>
<tr>
<td align="center">–</td>
<td>Parkinson disease/PARK1</td>
<td>163890/168601</td>
<td>4q22.1</td>
<td>90.747</td>
<td>91.018</td>
</tr>
<tr>
<td>Rieger type 1/RIEG1</td>
<td align="center">–</td>
<td>180500</td>
<td>4q25</td>
<td>111.758</td>
<td>111.779</td>
</tr>
<tr>
<td align="center">–</td>
<td>4q32.1-q32.2 Triple/Duplication syndrome</td>
<td>613603</td>
<td>4q32.1q32.2</td>
<td>157.356</td>
<td>161.615</td>
</tr>
<tr>
<td>Cri–du-Chat syndrome/CdCS</td>
<td align="center">–</td>
<td>123450</td>
<td>5p15.2-p15.33</td>
<td>0</td>
<td>11.777</td>
</tr>
<tr>
<td>Cornelia de Lange syndrome/CDLS</td>
<td>NIPBL microduplication</td>
<td>613174</td>
<td>5p13.2</td>
<td>36.997</td>
<td>37.033</td>
</tr>
<tr>
<td>spinal muscular atrophy/SMA</td>
<td align="center">–</td>
<td>253300</td>
<td>5q13.2</td>
<td>70.278</td>
<td>70.286</td>
</tr>
<tr>
<td>microdeletion 5q14.3</td>
<td align="center">–</td>
<td>600662</td>
<td>5q14.3</td>
<td>86.142</td>
<td>86.413</td>
</tr>
<tr>
<td>microdeletion 5q14.3-q15</td>
<td align="center">–</td>
<td>612881</td>
<td>5q14.3-q15</td>
<td>88.400</td>
<td>90.090</td>
</tr>
<tr>
<td>familial adenomatous polyposis/FAP</td>
<td align="center">–</td>
<td>175100</td>
<td>5q22.2</td>
<td>112.129</td>
<td>112.249</td>
</tr>
<tr>
<td align="center">–</td>
<td>adult-onset autosomal dominant leukodystrophy/ADLD</td>
<td>169500</td>
<td>5q23.2</td>
<td>126.046</td>
<td>126.233</td>
</tr>
<tr>
<td>PITX1 microdeletion</td>
<td align="center">–</td>
<td>602149</td>
<td>5q31.1</td>
<td>134.222</td>
<td>134.463</td>
</tr>
<tr>
<td>microdeletion 5q31.3</td>
<td align="center">–</td>
<td align="center">–</td>
<td>5q31.3</td>
<td>139.117</td>
<td>141.682</td>
</tr>
<tr>
<td align="center">–</td>
<td>Pseudo trisomy 13 syndrome</td>
<td>264480</td>
<td>5q35.1</td>
<td>170.222</td>
<td>171.584</td>
</tr>
<tr>
<td>microdeletion 5q35.1</td>
<td align="center">–</td>
<td align="center">–</td>
<td>5q35.1</td>
<td>172.592</td>
<td>172.595</td>
</tr>
<tr>
<td>parietal foramina/PFM</td>
<td align="center">–</td>
<td>168500</td>
<td>5q35.2</td>
<td>174.084</td>
<td>174.091</td>
</tr>
<tr>
<td>Sotos syndrome</td>
<td>microduplication 5q35</td>
<td>117550</td>
<td>5q35.2-q35.3</td>
<td>175.063</td>
<td>177.389</td>
</tr>
<tr>
<td>microdeletion 6p</td>
<td align="center">–</td>
<td>612582</td>
<td>6p25</td>
<td>0</td>
<td align="center">–</td>
</tr>
<tr>
<td>microdeletion 6p22.3</td>
<td align="center">–</td>
<td align="center">–</td>
<td>6p22.3</td>
<td>20.850</td>
<td>21.250</td>
</tr>
<tr>
<td>adrenal hyperplasia/AH</td>
<td align="center">–</td>
<td>201910</td>
<td>6p21.32</td>
<td>32.114</td>
<td>32,117</td>
</tr>
<tr>
<td>microdeletion 6p21.31</td>
<td align="center">–</td>
<td align="center">–</td>
<td>6p21.31</td>
<td>33.273</td>
<td>34.086</td>
</tr>
<tr>
<td>microdeletion 6q13–14</td>
<td align="center">–</td>
<td>613544</td>
<td>6q13–14</td>
<td>72.650</td>
<td>76.310</td>
</tr>
<tr>
<td>Prader–Willi like</td>
<td align="center">–</td>
<td>176270</td>
<td>6q16.2</td>
<td>100.943</td>
<td>101.018</td>
</tr>
<tr>
<td align="center">–</td>
<td>transient neonatal diabetes mellitus 1/TNDM1</td>
<td>601410</td>
<td>6q24.2</td>
<td>144.303</td>
<td>144.427</td>
</tr>
<tr>
<td>microdeletion 6q25.2-q25.3</td>
<td align="center">–</td>
<td>612863</td>
<td>6q25.2-q25.3</td>
<td>155.500</td>
<td>158.853</td>
</tr>
<tr>
<td>PARK2 microdeletion</td>
<td>PARK2 microduplication</td>
<td>602544</td>
<td>6q26</td>
<td>161.688</td>
<td>162.784</td>
</tr>
<tr>
<td>microdeletion 6q27 anosmia</td>
<td>Chondroma/CHDM</td>
<td>215400</td>
<td>6q27</td>
<td>165.554</td>
<td>170.762</td>
</tr>
<tr>
<td>Saethre–Chotzen syndrome/SCS</td>
<td align="center">–</td>
<td>101400</td>
<td>7p21.1</td>
<td>19.121</td>
<td align="center">–</td>
</tr>
<tr>
<td>Greig cephalopolysyndactyly/GCPS</td>
<td align="center">–</td>
<td>175700</td>
<td>7p14.1</td>
<td>41.967</td>
<td>42.243</td>
</tr>
<tr>
<td>Williams–Beuren syndrome/WBS</td>
<td>microduplication 7q11.23</td>
<td>609757/194050</td>
<td>7q11.23</td>
<td>71.971</td>
<td>74.255</td>
</tr>
<tr>
<td>WBS-distal deletion (RHBDD2, HIP1)</td>
<td align="center">–</td>
<td>613729</td>
<td>7q11.23</td>
<td>74.800</td>
<td>76.500</td>
</tr>
<tr>
<td>split hand/foot malformation 1/SHFM1</td>
<td align="center">–</td>
<td>183600/220600</td>
<td>7q21.3</td>
<td>95.370</td>
<td>96.619</td>
</tr>
<tr>
<td>microdeletion 7q22.1-q22.3</td>
<td align="center">–</td>
<td align="center">–</td>
<td>7q22.1-q22.3</td>
<td>101.040</td>
<td>104.560</td>
</tr>
<tr>
<td>autism/dyslexia microdeletion 7q31.1</td>
<td align="center">–</td>
<td align="center">–</td>
<td>7q31.1</td>
<td>110,654</td>
<td>111,266</td>
</tr>
<tr>
<td>speech-language-disorder 1/SPCH1</td>
<td align="center">–</td>
<td>602081</td>
<td>7q31</td>
<td>114.085</td>
<td>114.090</td>
</tr>
<tr>
<td>holoprosencephaly 3/HPE3</td>
<td align="center">–</td>
<td>142945</td>
<td>7q36.3</td>
<td>155.288</td>
<td>155.298</td>
</tr>
<tr>
<td align="center">–</td>
<td>triphalangeal thumb polysyndactyly syndrome/TPTS</td>
<td>174500</td>
<td>7q36.3</td>
<td>155.836</td>
<td>156.425</td>
</tr>
<tr>
<td>Currarino syndrome/CS</td>
<td align="center">–</td>
<td>176450</td>
<td>7q36.3</td>
<td>156.490</td>
<td>156.496</td>
</tr>
<tr>
<td>microdeletion 8p23.1</td>
<td>microduplication 8p23.1</td>
<td>179613</td>
<td>8p23.1</td>
<td>8.156</td>
<td>11.803</td>
</tr>
<tr>
<td>microdeletion 8p21.2</td>
<td align="center">–</td>
<td align="center">–</td>
<td>8p21.2</td>
<td>20.750</td>
<td>24.390</td>
</tr>
<tr>
<td>microdeletion 8p12p21</td>
<td align="center">–</td>
<td align="center">–</td>
<td>8p12p21</td>
<td>24.500</td>
<td>31.300</td>
</tr>
<tr>
<td align="center">–</td>
<td>microduplication 8q11.23</td>
<td>610928</td>
<td>8q11.23</td>
<td>53.450</td>
<td>54.050</td>
</tr>
<tr>
<td>CHARGE syndrome</td>
<td>microduplication 8q12</td>
<td>214800</td>
<td>8q12.2</td>
<td>61.754</td>
<td>61.942</td>
</tr>
<tr>
<td>microdeletion 8q12.3q13.2</td>
<td align="center">–</td>
<td align="center">–</td>
<td>8q12.3-q13.2</td>
<td>65.450</td>
<td>69.020</td>
</tr>
<tr>
<td>mesomelia-synostoses syndrome/MSS</td>
<td align="center">–</td>
<td>600383</td>
<td>8q13</td>
<td>70.541</td>
<td>70.908</td>
</tr>
<tr>
<td>microdeletion 8q21.11</td>
<td align="center">–</td>
<td>614230</td>
<td>8q21.11</td>
<td>77.389</td>
<td>77.929</td>
</tr>
<tr>
<td>nablus mask-like facial syndrome/NMLFS</td>
<td align="center">–</td>
<td>608156</td>
<td>8q21.3-q22.1</td>
<td>93.210</td>
<td>97.940</td>
</tr>
<tr>
<td>microdeletion 8q22.2q22.3</td>
<td align="center">–</td>
<td align="center">–</td>
<td>8q22.2-q22.3</td>
<td>100.690</td>
<td>104.560</td>
</tr>
<tr>
<td>Langer–Giedion syndrome/LGS</td>
<td align="center">–</td>
<td>150230</td>
<td>8q24.11</td>
<td>118.881</td>
<td>119.193</td>
</tr>
<tr>
<td>sex reversal syndrome 4/SRXY4</td>
<td align="center">–</td>
<td>154230</td>
<td>9p24.3</td>
<td>0</td>
<td>1.048</td>
</tr>
<tr>
<td>monosomy 9p syndrome</td>
<td align="center">–</td>
<td>158170</td>
<td>9pter-p22.3</td>
<td>0</td>
<td>16.168</td>
</tr>
<tr>
<td align="center">–</td>
<td>microduplication 9q21.11</td>
<td>613558</td>
<td>9q21.11</td>
<td>71.051</td>
<td>71.197</td>
</tr>
<tr>
<td>microdeletion 9q22.3</td>
<td>PTCH1 microduplication</td>
<td>601309</td>
<td>9q22.3</td>
<td>94.420</td>
<td>99.100</td>
</tr>
<tr>
<td>holoprosencephaly 7/HPE7</td>
<td align="center">–</td>
<td>610828</td>
<td>9q22.32</td>
<td>97.284</td>
<td>97.319</td>
</tr>
<tr>
<td>nail-patella syndrome/NPS</td>
<td align="center">–</td>
<td>161200</td>
<td>9q33.3</td>
<td>128.417</td>
<td>128.499</td>
</tr>
<tr>
<td>early infantile epileptic encephalopathy 4/EIEE4</td>
<td align="center">–</td>
<td>612164</td>
<td>9q34.11</td>
<td>129.414</td>
<td>129.495</td>
</tr>
<tr>
<td>microdeletion 9q34 (EHMT1)</td>
<td>microduplication 9q34 (EHMT1)</td>
<td>607001</td>
<td>9q34.3</td>
<td>136.950</td>
<td>140.200</td>
</tr>
<tr>
<td>subtelomere deletion 9q</td>
<td align="center">–</td>
<td>610253</td>
<td>9q34.3</td>
<td>139.473</td>
<td>140.273</td>
</tr>
<tr>
<td>hypoparathyroidism, sensorineural deafness, and renal disease/HDRS</td>
<td align="center">–</td>
<td>146255</td>
<td>10p15</td>
<td>8.137</td>
<td>8.157</td>
</tr>
<tr>
<td>Di George syndrome 2/DGS2</td>
<td align="center">–</td>
<td>601362</td>
<td>10p12.31</td>
<td>21.144</td>
<td>21.170</td>
</tr>
<tr>
<td>microdeletion 10q22-q23 (NRG3, GRID1)</td>
<td align="center">–</td>
<td align="center">–</td>
<td>10q22-q23</td>
<td>81.655</td>
<td>88.984</td>
</tr>
<tr>
<td>juvenile polyposis syndrome/JPS</td>
<td align="center">–</td>
<td>612242</td>
<td>10q23.2-q23.3</td>
<td>88,675</td>
<td>89.613</td>
</tr>
<tr>
<td align="center">–</td>
<td>Split-Hand/Foot Malformation 3/SHFM3</td>
<td>246560</td>
<td>10q24.32</td>
<td>102.977</td>
<td>103.445</td>
</tr>
<tr>
<td>microdeletion 10q25q26</td>
<td align="center">–</td>
<td>609625</td>
<td>10q25q26</td>
<td>117.098</td>
<td>qter</td>
</tr>
<tr>
<td>Beckwith–Wiedemann syndrome/BWS—Silver Russell syndrome/SRS microdeletion</td>
<td>Beckwith–Wiedemann syndrome/BWS—Silver Russell syndrome/SRS microduplication</td>
<td>130650</td>
<td>11p15.5</td>
<td>2.861</td>
<td>2.864</td>
</tr>
<tr>
<td>WAGR syndrome</td>
<td>microduplication 11p13</td>
<td>194072/612469</td>
<td>11p13</td>
<td>31.767</td>
<td>32.467</td>
</tr>
<tr>
<td>Potocki–Shaffer syndrome/PSS</td>
<td align="center">–</td>
<td>601224</td>
<td>11p11.2</td>
<td>43.905</td>
<td>46.080</td>
</tr>
<tr>
<td align="center">–</td>
<td>spinocerebellar ataxia type 20/SCA20</td>
<td>608687</td>
<td>11q12.2q12.3</td>
<td>61.210</td>
<td>61.503</td>
</tr>
<tr>
<td>microdeletion 11q14.1</td>
<td align="center">–</td>
<td align="center">–</td>
<td>11q14.1-q14.2</td>
<td>86.334</td>
<td>86.344</td>
</tr>
<tr>
<td>Jacobsen syndrome/JBS</td>
<td align="center">–</td>
<td>147791/188025</td>
<td>11q23.3-qter</td>
<td>115.400</td>
<td>134.452</td>
</tr>
<tr>
<td align="center">–</td>
<td>microduplication 12p13.31</td>
<td align="center">–</td>
<td>12p13.31</td>
<td>8.050</td>
<td>8.250</td>
</tr>
<tr>
<td>microdeletion 12q14</td>
<td align="center">–</td>
<td align="center">–</td>
<td>12q14</td>
<td>63.356</td>
<td>66.932</td>
</tr>
<tr>
<td>nasal speech-hypothyroidism microdeletion/NSH</td>
<td align="center">–</td>
<td align="center">–</td>
<td>12q15-q21.1</td>
<td>68.802</td>
<td>701.392</td>
</tr>
<tr>
<td>Noonan syndrome 1/NS1</td>
<td align="center">–</td>
<td>163950</td>
<td>12q24.1</td>
<td>111.341</td>
<td>111.432</td>
</tr>
<tr>
<td>microdeletion 13q12 (CRYL1)</td>
<td>microduplication 13q12 (CRYL1)</td>
<td align="center">–</td>
<td>13q12.11</td>
<td>19.710</td>
<td>19.910</td>
</tr>
<tr>
<td>spastic ataxia Charlevoix–Saguenay/SACS</td>
<td align="center">–</td>
<td>270550</td>
<td>13q12.12</td>
<td>22.336</td>
<td>23.807</td>
</tr>
<tr>
<td>microdeletion 13q12.3-q13.1</td>
<td align="center">–</td>
<td>600185</td>
<td>13q12.3-q13.1</td>
<td>31.137</td>
<td>31.871</td>
</tr>
<tr>
<td>retinoblastoma/RB1</td>
<td align="center">–</td>
<td>613884</td>
<td>13q14.2</td>
<td>47.776</td>
<td>47.954</td>
</tr>
<tr>
<td>Hirschsprung disease 2/HSCR2</td>
<td align="center">–</td>
<td>600155</td>
<td>13q22</td>
<td>77.369</td>
<td>77.391</td>
</tr>
<tr>
<td>holoprosencephaly5/HPE5</td>
<td align="center">–</td>
<td>609637</td>
<td>13q32.3</td>
<td>99.432</td>
<td>99.437</td>
</tr>
<tr>
<td>microdeletion 14q11.2</td>
<td align="center">–</td>
<td>613457</td>
<td>14q11.2</td>
<td>20.920</td>
<td>20.947</td>
</tr>
<tr>
<td>congenital Rett variant/CRV</td>
<td>microduplication 14q12</td>
<td>613454</td>
<td>14q12</td>
<td>28.300</td>
<td>30.000</td>
</tr>
<tr>
<td>microdeletion 14q22-q23</td>
<td align="center">–</td>
<td>607932</td>
<td>14q22-q23</td>
<td>53.486</td>
<td>60.261</td>
</tr>
<tr>
<td>autism spherocytosis microdeletion/ASC</td>
<td align="center">–</td>
<td align="center">–</td>
<td>14q23.2-q23.3</td>
<td>63.924</td>
<td>64.471</td>
</tr>
<tr>
<td>microdeletion 14q32.2</td>
<td align="center">–</td>
<td align="center">–</td>
<td>14q32.2</td>
<td>99.463</td>
<td>100.574</td>
</tr>
<tr>
<td>microdeletion 15q11.2 (NIPA1)</td>
<td>microduplication 15q11.2 (NIPA1)</td>
<td>608145</td>
<td>15q11.2</td>
<td>20.350</td>
<td>20.640</td>
</tr>
<tr>
<td>Angelman syndrome Typ1/AS1</td>
<td>microduplication 15</td>
<td>105830</td>
<td>15q11.2-q13.1</td>
<td>20.405</td>
<td>26.231</td>
</tr>
<tr>
<td>Angelman syndrome Typ2/AS2</td>
<td>microduplication 15</td>
<td>105830</td>
<td>15q11.2-q13.1</td>
<td>21.309</td>
<td>26.231</td>
</tr>
<tr>
<td>Prader–Willi syndrome Typ 1/ PWS1</td>
<td>microduplication 15</td>
<td>176270</td>
<td>15q11.2-q13.1</td>
<td>20.405</td>
<td>26.231</td>
</tr>
<tr>
<td>Prader–Willi syndrome Typ 2/ PWS2</td>
<td>microduplication 15</td>
<td>176270</td>
<td>15q11.2-q13.1</td>
<td>21.309</td>
<td>26.231</td>
</tr>
<tr>
<td>microdeletion 15q13.3 (CHRNA7)</td>
<td>microduplication 15q13.3 (CHRNA7)</td>
<td>612001</td>
<td>15q13.3</td>
<td>28.525</td>
<td>30.489</td>
</tr>
<tr>
<td>microdeletion 15q14</td>
<td align="center">–</td>
<td align="center">–</td>
<td>15q14</td>
<td>33.471</td>
<td>35.072</td>
</tr>
<tr>
<td>deafness and male infertility syndrome/DMIS</td>
<td align="center">–</td>
<td>611102</td>
<td>15q15.3</td>
<td>41.613</td>
<td>41.747</td>
</tr>
<tr>
<td>microdeletion 15q21</td>
<td align="center">–</td>
<td align="center">–</td>
<td>15q21</td>
<td>48.382</td>
<td>48.565</td>
</tr>
<tr>
<td>microdeletion 15q24 (BBS4,NPTN, NE01)</td>
<td align="center">–</td>
<td>601907</td>
<td>15q24</td>
<td>70.700</td>
<td>72.200</td>
</tr>
<tr>
<td>microdeletion 15q24</td>
<td>microduplication 15q24</td>
<td>613406</td>
<td>15q24</td>
<td>72.158</td>
<td>73.949</td>
</tr>
<tr>
<td>orofacial clefting/OC</td>
<td align="center">–</td>
<td>614294</td>
<td>15q24.3-q25.2</td>
<td>76.080</td>
<td>80.338</td>
</tr>
<tr>
<td>microdeletion 15q25</td>
<td align="center">–</td>
<td>614294</td>
<td>15q25</td>
<td>82.900</td>
<td>83.600</td>
</tr>
<tr>
<td>microdeletion 15q26.1</td>
<td align="center">–</td>
<td align="center">–</td>
<td>15q26.1</td>
<td>91.100</td>
<td>91.600</td>
</tr>
<tr>
<td>Fryns syndrome/FNS</td>
<td align="center">–</td>
<td>229850</td>
<td>15q26.2</td>
<td>92.238</td>
<td>96.520</td>
</tr>
<tr>
<td>microdeletion 15q26.2-qter</td>
<td align="center">–</td>
<td align="center">–</td>
<td>15q26.2-qter</td>
<td>95.600</td>
<td>100.339</td>
</tr>
<tr>
<td>ATR-16-syndrome</td>
<td align="center">–</td>
<td>141750</td>
<td>16p13.3</td>
<td>0</td>
<td>774</td>
</tr>
<tr>
<td>tuberous sclerosis microdeletion syndrome/PKDTS</td>
<td>tuberous sclerosis microduplication</td>
<td>600273</td>
<td>16p13.3</td>
<td>2.038</td>
<td>2.079</td>
</tr>
<tr>
<td>Rubinstein–Taybi syndrome 1/RSTS1</td>
<td>Rubinstein–Taybi-microduplication</td>
<td>610543/613458</td>
<td>16p13.3</td>
<td>3.762</td>
<td>3.801</td>
</tr>
<tr>
<td>microdeletion 16p13.1 (MYH11)</td>
<td>microduplication 16p13.1 (MYH11)</td>
<td>132900</td>
<td>16p13.1</td>
<td>14.789</td>
<td>16.281</td>
</tr>
<tr>
<td>microdeletion 16p11.2-p12.2</td>
<td>microduplication 16p11.2-p12.2</td>
<td>613604</td>
<td>16p11.2-p12.2</td>
<td>21.521</td>
<td>28.950</td>
</tr>
<tr>
<td>microdeletion 16p12.1 (EEF2K,CDR2)</td>
<td>microduplication 16p12.2 (EEF2K,CDR2)</td>
<td>117340/606968</td>
<td>16p12.1</td>
<td>21.850</td>
<td>22.370</td>
</tr>
<tr>
<td>16q11.2 distal microdeletion (SH2B1)</td>
<td>16q11.2 distal microduplication (SH2B1)</td>
<td align="center">–</td>
<td>16q11.2</td>
<td>28.680</td>
<td>29.020</td>
</tr>
<tr>
<td>microdeletion 16p11.2 (TBX6)</td>
<td>microduplication 16p11.2 (TBX6)</td>
<td>602427/611913</td>
<td>16p11.2</td>
<td>29.551</td>
<td>30.059</td>
</tr>
<tr>
<td>microdeletion 16q11.2-q12.1</td>
<td align="center">–</td>
<td align="center">–</td>
<td>16q11.2-q12.1</td>
<td>45.401</td>
<td>45.579</td>
</tr>
<tr>
<td>microdeletion 16q21-q22</td>
<td align="center">–</td>
<td align="center">–</td>
<td>16q21-q22</td>
<td>65.621</td>
<td>65.692</td>
</tr>
<tr>
<td>microdeletion 16q12.1-q12.2</td>
<td align="center">–</td>
<td align="center">–</td>
<td>16q12.1-q12.2</td>
<td>48.018</td>
<td>52.726</td>
</tr>
<tr>
<td>microdeletion 16q24.1</td>
<td align="center">–</td>
<td>601089</td>
<td>16q24.1</td>
<td>82.908</td>
<td>85.153</td>
</tr>
<tr>
<td>FANCA deletion</td>
<td align="center">–</td>
<td>227650</td>
<td>16q24.3</td>
<td>88.392</td>
<td>88.411</td>
</tr>
<tr>
<td>Miller–Dieker syndrome/MDLS</td>
<td>Miller–Dieker microduplication</td>
<td>247200/613215</td>
<td>17p13.3</td>
<td>0</td>
<td>2.492</td>
</tr>
<tr>
<td>microdeletion 17p13.3 (YWHAE)</td>
<td>microduplication 17p13.3 (YWHAE)</td>
<td>247200/613215</td>
<td>17p13.3</td>
<td>2–310</td>
<td>2.870</td>
</tr>
<tr>
<td>microdeletion 17p13.1</td>
<td align="center">–</td>
<td>613776</td>
<td>17p13.1</td>
<td>7.429</td>
<td>7.937</td>
</tr>
<tr>
<td>hereditary liability to pressure palsies/HNPP</td>
<td>Charcot–Marie–Tooth 1A/CMT1A</td>
<td>162500/118220</td>
<td>17p12</td>
<td>13.855</td>
<td>15.375</td>
</tr>
<tr>
<td>Smith–Magenis syndrome/SMS</td>
<td>Potocki–Lupski syndrome/PTLS</td>
<td>610883</td>
<td>17p11.2</td>
<td>16.527</td>
<td>20.423</td>
</tr>
<tr>
<td>neurofibromatosis 1/NF1</td>
<td>microduplication NF1</td>
<td>613675</td>
<td>17q11</td>
<td>26.102</td>
<td>27.243</td>
</tr>
<tr>
<td>microdeletion 17q11.2-q12</td>
<td align="center">–</td>
<td align="center">–</td>
<td>17q11.2-q12</td>
<td>26.280</td>
<td>31.030</td>
</tr>
<tr>
<td>microdeletion 17q12a</td>
<td align="center">–</td>
<td align="center">–</td>
<td>17q12</td>
<td>31.977</td>
<td>33.150</td>
</tr>
<tr>
<td>renal cysts and diabetes syndrome/RCAD</td>
<td>microduplication 17q12b</td>
<td>137920</td>
<td>17q12</td>
<td>31.830</td>
<td>33.350</td>
</tr>
<tr>
<td>Van Buchem disease/VBCH</td>
<td align="center">–</td>
<td>239100</td>
<td>17q12-q21</td>
<td>39.187</td>
<td>39.192</td>
</tr>
<tr>
<td>microdeletion 17q21.3 (MAPT)</td>
<td>microduplication 17q21.31 (MAPT)</td>
<td>610443/613533</td>
<td>17q21.3</td>
<td>40.988</td>
<td>41.566</td>
</tr>
<tr>
<td>microdeletion 17q21.31-q21.32</td>
<td align="center">–</td>
<td align="center">–</td>
<td>17q21.31-q21.32</td>
<td>41.769</td>
<td>43.113</td>
</tr>
<tr>
<td>microdeletion 17q22-q23.2</td>
<td align="center">–</td>
<td align="center">–</td>
<td>17q22–23.2</td>
<td>48.300</td>
<td>54.200</td>
</tr>
<tr>
<td align="center">–</td>
<td>microduplication 17q23.1–23.2</td>
<td>613355/613618</td>
<td>17q23.1–23.2</td>
<td>55.457</td>
<td>57.693</td>
</tr>
<tr>
<td>microdeletion 17q24.2-q24.3</td>
<td align="center">–</td>
<td align="center">–</td>
<td>17q24.2-q24.3</td>
<td>61.730</td>
<td>65.690</td>
</tr>
<tr>
<td>carney complex syndrome 1/CNC1</td>
<td align="center">–</td>
<td>160980</td>
<td>17q24.2-q24.3</td>
<td>63.260</td>
<td>65.594</td>
</tr>
<tr>
<td align="center">–</td>
<td>microduplication 17q24.3</td>
<td>278850</td>
<td>17q24.3</td>
<td>65.642</td>
<td>66.847</td>
</tr>
<tr>
<td>holoprosencephaly 4/HPE4</td>
<td align="center">–</td>
<td>146390</td>
<td>18p11.31</td>
<td>3.445</td>
<td>3.448</td>
</tr>
<tr>
<td>proximal 18q microdeletion</td>
<td align="center">–</td>
<td>601808</td>
<td>18q12.3-q21.1</td>
<td>37.500</td>
<td>42.500</td>
</tr>
<tr>
<td>Pitt–Hopkins syndrome/PTHS</td>
<td align="center">–</td>
<td>610954</td>
<td>18q21.1</td>
<td>51.083</td>
<td>51.282</td>
</tr>
<tr>
<td>microdeletion 18q22.3-q23</td>
<td align="center">–</td>
<td>607842</td>
<td>18q22.3-q23</td>
<td>70.474</td>
<td>73.111</td>
</tr>
<tr>
<td align="center">–</td>
<td>Sotos-like microduplication 19p13.2</td>
<td align="center">–</td>
<td>19p13.2</td>
<td>9.107</td>
<td>11.094</td>
</tr>
<tr>
<td>microdeletion 19p13.13</td>
<td>microduplication 19p13.13</td>
<td>613638</td>
<td>19p13.13</td>
<td>12.793</td>
<td>13.104</td>
</tr>
<tr>
<td>microdeletion 19p13.12</td>
<td align="center">–</td>
<td align="center">–</td>
<td>19p13.12</td>
<td>14,119</td>
<td>14,439</td>
</tr>
<tr>
<td>microdeletion 19p13.11</td>
<td align="center">–</td>
<td align="center">–</td>
<td>19p13.11</td>
<td>16.485</td>
<td>17.554</td>
</tr>
<tr>
<td>microdeletion 19q13.11</td>
<td align="center">–</td>
<td>613026</td>
<td>19q13.11</td>
<td>37.300</td>
<td>40.200</td>
</tr>
<tr>
<td>Diamond–Blackfan anemia/DBA</td>
<td align="center">–</td>
<td>105650</td>
<td>19q13.2</td>
<td>47.056</td>
<td>47.067</td>
</tr>
<tr>
<td>microdeletion 20p12.3</td>
<td align="center">–</td>
<td>112261</td>
<td>20p12.3</td>
<td>6.907</td>
<td>7.012</td>
</tr>
<tr>
<td>Alagille syndrome 1/ALGS1</td>
<td align="center">–</td>
<td>118450</td>
<td>20p12</td>
<td>10.478</td>
<td>10.669</td>
</tr>
<tr>
<td>microdeletion 20q13.13-q13.2</td>
<td align="center">–</td>
<td align="center">–</td>
<td>20q13.13-q13.2</td>
<td>49.760</td>
<td>50.840</td>
</tr>
<tr>
<td>Albright hereditary osteodystrophy/AHO</td>
<td align="center">–</td>
<td>103580</td>
<td>20q13.32</td>
<td>56.900</td>
<td>56,92</td>
</tr>
<tr>
<td>microdeletion 20q13.33</td>
<td align="center">–</td>
<td align="center">–</td>
<td>20q13.33</td>
<td>61.246</td>
<td>62.376</td>
</tr>
<tr>
<td>microdeletion 21q21.1</td>
<td align="center">–</td>
<td align="center">–</td>
<td>21q21.1</td>
<td>19.950</td>
<td>20.250</td>
</tr>
<tr>
<td align="center">–</td>
<td>microduplication 21q21.3</td>
<td align="center">–</td>
<td>21q21.3</td>
<td>25.960</td>
<td>26.470</td>
</tr>
<tr>
<td>platelet disorder/PD</td>
<td align="center">–</td>
<td>601399</td>
<td>21q22.12</td>
<td>34.743</td>
<td>35.343</td>
</tr>
<tr>
<td align="center">–</td>
<td>Down syndrome/DS</td>
<td>190685</td>
<td>21q22.13</td>
<td>37.300</td>
<td>38.502</td>
</tr>
<tr>
<td align="center">–</td>
<td>Cat-Eye syndrome/CES</td>
<td>115470</td>
<td>22p11.1-q11.21</td>
<td>0</td>
<td>16.977</td>
</tr>
<tr>
<td>Di George syndrome/CATCH22/DGS</td>
<td>microduplication 22q11.2</td>
<td>608363/145410</td>
<td>22q11.21-q11.23</td>
<td>16.932</td>
<td>20.672</td>
</tr>
<tr>
<td>distal microdeletion 22q11.2 (BCR, MAPK1)</td>
<td>distal microduplication 22q11.2 (BCR, MAPK1)</td>
<td>611867</td>
<td>22q11.2</td>
<td>20.446</td>
<td>22.026</td>
</tr>
<tr>
<td>neurofibromatosis 2 microdeletion syndrome</td>
<td align="center">–</td>
<td>101000</td>
<td>22q12.2</td>
<td>28.330</td>
<td>28.425</td>
</tr>
<tr>
<td>Phelan–McDermid syndrome</td>
<td>microduplication 22q13 (SHANK3)</td>
<td>606232</td>
<td>22q13</td>
<td>49.449</td>
<td>49.691</td>
</tr>
<tr>
<td>Leri–Weill dyschondrosteosis/LWD</td>
<td align="center">–</td>
<td>127300</td>
<td>Xp22.33</td>
<td>0</td>
<td>724</td>
</tr>
<tr>
<td>X-Linked autism-2/AUTSX2</td>
<td align="center">–</td>
<td>300495</td>
<td>Xp22.32-p22.31</td>
<td>5.818</td>
<td>6.157</td>
</tr>
<tr>
<td>Steroid sulphatase deficiency/STS</td>
<td align="center">–</td>
<td>308100</td>
<td>Xp22.31</td>
<td>6.452</td>
<td>8.128</td>
</tr>
<tr>
<td>Kallmann syndrome 1/KAL1</td>
<td align="center">–</td>
<td>308700</td>
<td>Xp22.31</td>
<td>8.457</td>
<td>8.660</td>
</tr>
<tr>
<td>MIDAS syndrome</td>
<td align="center">–</td>
<td>309801</td>
<td>Xp22.2</td>
<td>11.039</td>
<td>11.659</td>
</tr>
<tr>
<td>Nance–Horan syndrome/NHS</td>
<td align="center">–</td>
<td>302350</td>
<td>Xp22.13</td>
<td>16.853</td>
<td>17.768</td>
</tr>
<tr>
<td>microdeletion Xp22.11</td>
<td align="center">–</td>
<td>300830</td>
<td>Xp22.11</td>
<td>22.928</td>
<td>23.309</td>
</tr>
<tr>
<td>X-linked congenital adrenal hypoplasia/AHC</td>
<td>DAX1 microduplication</td>
<td>300679</td>
<td>Xp21.2</td>
<td>30.233</td>
<td>30.237</td>
</tr>
<tr>
<td>complex glycerol kinase/CGK</td>
<td align="center">–</td>
<td>300679</td>
<td>Xp21.2</td>
<td>30.233</td>
<td>30.659</td>
</tr>
<tr>
<td>muscular dystrophy Duchenne/DMD</td>
<td align="center">–</td>
<td>310200</td>
<td>Xp21.2</td>
<td>32.445</td>
<td>33.268</td>
</tr>
<tr>
<td>Xp11.3 deletion syndrome</td>
<td align="center">–</td>
<td>300578</td>
<td>Xp11.3</td>
<td>46.193</td>
<td>46.627</td>
</tr>
<tr>
<td>Goltz syndrome/GS</td>
<td align="center">–</td>
<td>305600</td>
<td>Xp11.23</td>
<td>48.252</td>
<td>48.264</td>
</tr>
<tr>
<td align="center">–</td>
<td>17-beta-hydroxysteroid dehydrogenase X/HSD</td>
<td>300801</td>
<td>Xp11.22</td>
<td>53.467</td>
<td>53.730</td>
</tr>
<tr>
<td align="center">–</td>
<td>microduplication Xq12q13.1</td>
<td>300127</td>
<td>Xq12-q13.1</td>
<td>67.435</td>
<td>68.633</td>
</tr>
<tr>
<td>X inactivation specific transcript/XIST</td>
<td align="center">–</td>
<td>314670</td>
<td>Xq13.2</td>
<td>72.863</td>
<td>73.063</td>
</tr>
<tr>
<td>Bruton agammaglobulinemia/XLA</td>
<td align="center">–</td>
<td>300755</td>
<td>Xq22.1</td>
<td>100.490</td>
<td>100.497</td>
</tr>
<tr>
<td>microdeletion Xq22.2</td>
<td>Pelizaeus–Merzbacher microduplication/PMD</td>
<td>312080</td>
<td>Xq22.2</td>
<td>102.609</td>
<td>103.098</td>
</tr>
<tr>
<td>microdeletion Xq22.3q23</td>
<td align="center">–</td>
<td>300194/303631</td>
<td>Xq22.3-q23</td>
<td>107.214</td>
<td>110.239</td>
</tr>
<tr>
<td>lymphoproliferative syndrome 1/XLP1</td>
<td align="center">–</td>
<td>308240</td>
<td>Xq25</td>
<td>123.308</td>
<td>123.335</td>
</tr>
<tr>
<td align="center">–</td>
<td>X-linked hypopituitarism/SRXX3</td>
<td>300833</td>
<td>Xq27.1</td>
<td>139.413</td>
<td>139.415</td>
</tr>
<tr>
<td>fragile site mental retardation 1/FMR1</td>
<td align="center">–</td>
<td>309550</td>
<td>Xq27.3</td>
<td>146.801</td>
<td>146.840</td>
</tr>
<tr>
<td>microdeletion Xq28</td>
<td align="center">–</td>
<td align="center">–</td>
<td>Xq28</td>
<td>147.043</td>
<td>147.543</td>
</tr>
<tr>
<td>Rett syndrome/RS</td>
<td>MECP2 microduplication</td>
<td>300475/300815/ 300845</td>
<td>Xq28</td>
<td>152.535</td>
<td>153.044</td>
</tr>
<tr>
<td>sex-determining region Y/SRY</td>
<td align="center">–</td>
<td>480000</td>
<td>Yp11.31</td>
<td>2.715</td>
<td>2.716</td>
</tr>
<tr>
<td>AZFa microdeletion</td>
<td align="center">–</td>
<td>415000</td>
<td>Yq11.21</td>
<td>12.934</td>
<td>13.664</td>
</tr>
<tr>
<td>AZFb microdeletion</td>
<td align="center">–</td>
<td>415000</td>
<td>Yq11.221- q11.223</td>
<td>18.698</td>
<td>24.475</td>
</tr>
<tr>
<td>AZFb+c microdeletion</td>
<td align="center">–</td>
<td>415000</td>
<td>Yq11.221-q11.23</td>
<td>18.474</td>
<td>26.203</td>
</tr>
<tr>
<td>AZFc microdeletion</td>
<td align="center">–</td>
<td>415000</td>
<td>Yq11.223-q11.23</td>
<td>23.387</td>
<td>26.203</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0022155412440001">
<p>Reported genes in certain MMSs are given in italics in brackets; abbreviations that were also used in <xref ref-type="fig" rid="fig2-0022155412440001">Fig. 2</xref> are given in capital letters after the slash. If known, the OMIM number is reported as well as the cytogenetic localization and start and end positions in kilobasepairs (kb), human genome version 18 [hg18]. Additional information on locus specific bacterial artificial chromosomes for every region, as well as the reference are given in a supplementary table. Dash/empty stands for no known reciprocal MMS up to Janurary 2012.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig2-0022155412440001" position="float">
<label>Figure 2.</label>
<caption>
<p>Schematic overview of all genomic microdeletion and microduplication regions reported at least twice. Red arrows indicate reported microdeletions, blue arrows microduplications, and mixed red/blue arrows reciprocal microduplication and microdeletion regions. For details on each indicated region and abbreviations, refer to <xref ref-type="table" rid="table1-0022155412440001">Table 1</xref>.</p>
</caption>
<graphic xlink:href="10.1369_0022155412440001-fig2.tif"/>
</fig>
</sec>
<sec id="section2-0022155412440001">
<title>Causes for Recurrence of MMSs</title>
<p>The basis of recurrent genomic rearrangements such as deletions, duplications, insertions, inversions, and translocations is the architecture of the primate/human genome. Innumerable repetitive elements serve as substrates for illegitimate intra- or interchromosomal/chromatide recombination during meiosis as well as in mitosis. This human specific genomic instability is not only causative, for example, for MMSs, but also has a great impact on genome evolution and flexibility in terms of gaining new gene functions or direct gene dosage effects by euchromatic copy number alterations (<xref ref-type="bibr" rid="bibr19-0022155412440001">Marques-Bonet and Eichler, 2009</xref>; <xref ref-type="bibr" rid="bibr5-0022155412440001">Gazave et al. 2011</xref>). Most recurrent genomic rearrangements are mediated by sequences such as segmental duplications (<xref ref-type="bibr" rid="bibr2-0022155412440001">Bailey and Eichler, 2006</xref>) and low copy repeats flanking a certain region and allow NAHR leading to a high number of same-size de novo rearrangements (<xref ref-type="bibr" rid="bibr25-0022155412440001">Stankiewicz and Lupski 2002</xref>) or SINEs/LINEs/LTRs (<xref ref-type="bibr" rid="bibr12-0022155412440001">Korbel et al. 2007</xref>; <xref ref-type="bibr" rid="bibr10-0022155412440001">Kidd et al. 2008</xref>). The second, rarer cause of genomic rearrangements is non-homologous end joining (NHEJ) following double stranded breaks, which is a cell repair mechanism and not directly mediated by specific sequence features (<xref ref-type="bibr" rid="bibr15-0022155412440001">Lieber 2008</xref>). NHEJ can affect the same region but not the exact breakpoint in a group of patients covering a dosage-sensitive gene in the shortest region of overlap that all patients share. Also, NHEJ appears to be common in instable genome regions such as fragile sites, where some of the microdeletions and duplications are located (<xref ref-type="bibr" rid="bibr23-0022155412440001">Schwartz et al. 2005</xref>; <xref ref-type="bibr" rid="bibr3-0022155412440001">Bena et al. 2010</xref>; <xref ref-type="bibr" rid="bibr21-0022155412440001">Mrasek et al. 2010</xref>). The third proposed model is DNA replication–based fork stalling and template switching, which accounts for complex rearrangements and is at least facilitated by one recurrent breakpoint through specific elements such as palindrome or cruciform DNA sequences (<xref ref-type="bibr" rid="bibr13-0022155412440001">Lee C et al. 2007</xref>).</p>
<p>Moreover, recurrent MMSs can arise from an inversion polymorphism in one of the parental genomes (e.g., <xref ref-type="bibr" rid="bibr6-0022155412440001">Gimelli et al. 2003</xref>; <xref ref-type="bibr" rid="bibr11-0022155412440001">Koolen et al. 2006</xref>) or from a balanced translocation (<xref ref-type="bibr" rid="bibr24-0022155412440001">Shaffer 2001</xref>). These inversion polymorphisms occur between inverted homologous sequences and are predisposed for NAHR in meiosis through inversion loop formation leading to recombinant products with deletions and duplications (<xref ref-type="bibr" rid="bibr4-0022155412440001">Bhatt et al. 2009</xref>).</p>
</sec>
<sec id="section3-0022155412440001">
<title>Methods to Detect and Analyze MMSs</title>
<sec id="section4-0022155412440001">
<title>Genomic Microarrays</title>
<p>Genomic microarrays refer to the principle of chromosome-based comparative genomic hybridization (CGH; <xref ref-type="bibr" rid="bibr9-0022155412440001">Kallioniemi et al. 1992</xref>), where test DNA and control DNA are differentially labeled, mixed in a 1:1 ratio, and hybridized together with Cot 1 DNA to metaphase spreads of a normal donor. This special fluorescence in situ hybridization (FISH) procedure results in a yellow staining of regions unaffected by CNV. Green and red colors along the chromosomes indicate genetic loss or gain in the DNA derived from the patient. Currently, hybridization is no longer done on metaphase spreads but on slides with spots of defined genomic sequences. This leads to a higher and better resolution compared with CGH depending on the number and the size of the probes used (<xref ref-type="bibr" rid="bibr22-0022155412440001">Pinkel et al. 1998</xref>; <xref ref-type="bibr" rid="bibr13-0022155412440001">Lee C et al. 2007</xref>). Besides copy number alterations, single nucleotide polymorphism (SNP)–based aCGH provides additional information on loss of heterozygosity, indicating a deletion or uniparental isodisomy.</p>
<p>Depending on the resolution, target size of the different platforms [bacterial artificial chromosomes (BACs), fosmids, oligonucleotides, SNPs], and the analysis criteria, MMSs as well as benign CNVs can be detected with varying accuracy. Thus, especially for benign CNVs, problems may arise when data from different platforms are compared by annotating them, for example, in the “database of genomic variants” (DGV). The exact sizes of the corresponding benign CNV might be available after the currently ongoing “1000 genomes project” (<xref ref-type="bibr" rid="bibr26-0022155412440001">Sudmant et al. 2010</xref>) is finished.</p>
<p>In most cases, aCGH is used as a genome-wide screening method. Therefore, after all technical problems are solved, the main challenge is in the interpretation of all the genomic data. This step, together with the verification of an aberration (see below), is the most labor intensive. The most critical decision is whether a CNV is considered benign or disease causative, along with final interpretation.</p>
</sec>
<sec id="section5-0022155412440001">
<title>Fluorescence In Situ Hybridization</title>
<p>Molecular cytogenetics, especially the FISH technique, is used for direct analysis of a certain suspected MMS critical region by applying locus-specific DNA probes. FISH is used when a physician suspects a specific MMS or for verification of aCGH data. The advantage of the FISH approach is that single-cell information in the context of metaphase chromosomes becomes available. Besides the visualization of a balanced chromosomal aberration in a parent (leading to unbalanced situations in the index patient), mosaicism and complex rearrangements in a patient can also be detected (<xref ref-type="bibr" rid="bibr20-0022155412440001">Mkrtchyan et al. 2010</xref>; <xref ref-type="fig" rid="fig3-0022155412440001">Fig. 3</xref>).</p>
<fig id="fig3-0022155412440001" position="float">
<label>Figure 3.</label>
<caption>
<p>(A) Example of microdeletion findings in array comparative genomic hybridization (aCGH) (Agilent Human Genome CGH Microarray 180k) in a female with karyotype 46,XX. The patient showed two de novo microdeletions (hg18): arr 16p12.1p11.2(22.665685–28.536945)x1/del(16)(p12.1p11.2)(5.871269–6.106456 Mb) arr 16q23.3q24.1(80.662135–84.286121)x1/del(16)(q23.3q24.1)(3.623986–3.648342 Mb) (B) The aCGH result was confirmed by fluorescence in situ hybridization with bacterial artificial chromosome clones located in the deletion regions. The microdeletions were confirmed on metaphase chromosomes and interphase nuclei.</p>
</caption>
<graphic xlink:href="10.1369_0022155412440001-fig3.tif"/>
</fig>
<p>One important limitation of the FISH approach is that the size of locus-specific probes should not be less than 10 kb (<xref ref-type="bibr" rid="bibr17-0022155412440001">Liehr et al. 1997</xref>). Furthermore, duplications are harder to verify by FISH than deletions; however, this drawback can be overcome by analysis of interphase nuclei in addition to metaphase spreads and/or the use of software signal intensity and size measurements (<xref ref-type="bibr" rid="bibr28-0022155412440001">Weise et al. 2008</xref>).</p>
<p>For classic, that is, well-known, MMSs, a panel of commercial available probes can be used. For all other genomic regions to be tested for CNVs, BACs and fosmids generated by the human genome project with annotated sequence/location/size information are good sources for directed microduplication and deletion testing (<xref ref-type="bibr" rid="bibr29-0022155412440001">Weise et al. 2009</xref>). A list with suggested BAC probes for the currently known MMSs regions is given in Suppl. Table 1.</p>
</sec>
<sec id="section6-0022155412440001">
<title>Quantitative Polymerase Chain Reaction</title>
<p>Quantitative polymerase chain reaction (qPCR) was initially established as a method for quantifying different levels of gene expression. However, under the need to verify aCGH results, qPCR is now also routinely applied to detect CNVs (<xref ref-type="bibr" rid="bibr30-0022155412440001">Weksberg et al. 2005</xref>). The qPCR technique provides a quantitative measurement of DNA CNVs of (nearly) any region of interest. The main limitations or problems are to find accurate primer pairs, to optimize the PCR conditions, and to detect mosaicism. Additionally, when using the parents of an index patient for CNV verification, balanced rearrangements with a higher recurrence risk in offspring are not recognizable.</p>
</sec>
<sec id="section7-0022155412440001">
<title>Multiplex Ligation-Dependent Probe Amplification</title>
<p>Multiplex ligation-dependent probe amplification (MLPA) is a directed multiplex PCR-based method. Only those primers that hybridize to the target sequences are amplified, and the resulting products can be analyzed by capillary electrophoresis. MLPA allows the detection of abnormal copy numbers of up to 50 different genomic sequences at the same time. Comparing the peak pattern obtained to that of reference samples indicates which sequences show aberrant copy numbers. The technique is commercially available for several sets of MMSs and therefore can serve as a time- and cost-reduced first or second screening step method (<xref ref-type="bibr" rid="bibr8-0022155412440001">Jehee et al. 2011</xref>). Again, the limitations are the same as in aCGH and qPCR: no proper detection of mosaicism and no verification of balanced origin in one parent. In addition, MLPA has the disadvantage that it covers only a limited number of loci. Furthermore, for newly described MMSs, a specific MLPA test has to be designed.</p>
</sec>
</sec>
<sec id="section8-0022155412440001">
<title>Databases for MMSs</title>
<p>To facilitate the analysis, especially of aCGH data, several databases are available summarizing genomic imbalances under different aspects. Before using these databases, one should check which version of the human genome sequence is used in one’s own aCGH platform and the database, as the coordinates move in different versions. The currently used version is hg19 or Build 37.3, but not all databases listed below refer to this version and need to be updated or converted by the user.</p>
<p>The first step for analysis and interpretation of aCGH results is the classification of a detected CNV as benign or disease causative. This question can be answered best by the use of genome browsers showing both reported benign and pathological CNVs, such as the genome browser from the University of California, Santa Cruz (UCSC; <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgGateway">http://genome.ucsc.edu/cgi-bin/hgGateway</ext-link>), the U.S. National Institutes of Health genome browser (NCBI; <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link>), or the Ensemble genome browser (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/Homo_sapiens">http://www.ensembl.org/Homo_sapiens</ext-link>). These genome browsers also provide information on BAC or fosmid clones that can be used for FISH verification of the CNV. Furthermore, the direct sequence can be downloaded or BLASTed for qPCR and MLPA design. Some of the genome browsers’ subdatabases are also directly available.</p>
<sec id="section9-0022155412440001">
<title>Copy Number Variation and Polymorphism</title>
<list id="list1-0022155412440001" list-type="bullet">
<list-item><p>Database of genomic variants (DGV): <ext-link ext-link-type="uri" xlink:href="http://projects.tcag.ca/variation">http://projects.tcag.ca/variation</ext-link></p></list-item>
<list-item><p>Catalogue of structural and copy number variation in the human genome</p></list-item>
<list-item><p>Chromosome Anomaly Collection: <ext-link ext-link-type="uri" xlink:href="http://www.ngrl.org.uk/Wessex/collection">http://www.ngrl.org.uk/Wessex/collection</ext-link></p></list-item>
<list-item><p>Collection of Unbalanced Chromosome Abnormalities (UBCAs) and Euchromatic Variants (EVs) visible by light microscope but without any phenotypic effect</p></list-item>
<list-item><p>Small supernumerary marker chromosomes. <ext-link ext-link-type="uri" xlink:href="http://www.med.uni-jena.de/fish/sSMC/00START.htm">http://www.med.uni-jena.de/fish/sSMC/00START.htm</ext-link></p></list-item>
<list-item><p>Collection of all available case reports on small supernumerary marker chromosomes (sSMCs) with definition of critical regions for partial trisomies due to the presence of sSMCs</p></list-item>
</list>
</sec>
<sec id="section10-0022155412440001">
<title>Catalogues of Pathological Imbalances</title>
<list id="list2-0022155412440001" list-type="bullet">
<list-item><p>Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources (DECIPHER): <ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/syndromes">https://decipher.sanger.ac.uk/syndromes</ext-link></p></list-item>
<list-item><p>An interactive Web-based database that incorporates a suite of tools designed to aid the interpretation of submicroscopic chromosomal imbalance</p></list-item>
<list-item><p>European Cytogeneticists Association Register of Unbalanced Chromosome Aberrations (ECARUCA): <ext-link ext-link-type="uri" xlink:href="http://umcecaruca01.extern.umcn.nl:8080/ecaruca/ecaruca.jsp">http://umcecaruca01.extern.umcn.nl:8080/ecaruca/ecaruca.jsp</ext-link></p></list-item>
<list-item><p>Database that collects and provides cytogenetic and clinical information on rare chromosomal disorders, including microdeletions and microduplications</p></list-item>
<list-item><p>The Chromosome Microdeletion/duplication Collection: <ext-link ext-link-type="uri" xlink:href="http://www.ngrl.org.uk/wessex/microdel_collection.htm">http://www.ngrl.org.uk/wessex/microdel_collection.htm</ext-link></p></list-item>
<list-item><p>Collection of MMS with the aim to interpret results of array CGH analysis</p></list-item>
</list>
</sec>
<sec id="section11-0022155412440001">
<title>Literature and Educational Resources</title>
<list id="list3-0022155412440001" list-type="bullet">
<list-item><p>Chromosomal Variation in Man: <ext-link ext-link-type="uri" xlink:href="http://www.wiley.com/legacy/products/subject/life/borgaonkar/">http://www.wiley.com/legacy/products/subject/life/borgaonkar/</ext-link></p></list-item>
<list-item><p>Interactive database and searching tool by chromosomes and regions on reviewed literature on all common and rare chromosomal alterations and abnormalities</p></list-item>
<list-item><p>Online Mendelian inheritance in man (OMIM): <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/omim">http://www.ncbi.nlm.nih.gov/omim</ext-link></p></list-item>
<list-item><p>Comprehensive, authoritative, and timely compendium of human genes and genetic phenotypes with several search options</p></list-item>
<list-item><p>GeneReviews: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK1116">http://www.ncbi.nlm.nih.gov/books/NBK1116</ext-link></p></list-item>
<list-item><p>Expert-authored, peer-reviewed disease descriptions that apply genetic testing to the diagnosis, management, and genetic counseling of patients and families with specific inherited conditions</p></list-item>
<list-item><p>Orpha net: <ext-link ext-link-type="uri" xlink:href="http://www.orpha.net">http://www.orpha.net</ext-link></p></list-item>
<list-item><p>Reference portal for information on rare diseases and orphan drugs for helping to improve the diagnosis, care, and treatment of patients with rare diseases</p></list-item>
</list>
</sec>
</sec>
<sec id="section12-0022155412440001">
<title>Conclusion and Outlook</title>
<p>Submicroscopic microdeletions and microduplications are only one aspect of variations taking place in the human genome. As most MMSs patients are unable to reproduce due to the severity of their intellectual disability, these kinds of diseases are more an expression of the structure of the human genome than inherited disorders. Due to recent progress in current diagnostic panels, MMSs can now be discovered during conventional diagnostics. Keeping in mind the limitations of every technique per se, clinicians should analyze patients with intellectual disability using careful stepwise analysis. Detection of whole chromosome trisomies and monosomies as well as gross chromosomal rearrangements should be studied via banding and molecular cytogenetic techniques. Such aberrations, especially when present in low mosaic levels, might be easily missed when only performing targeted molecular techniques such as qPCR or MLPA alone. Targeted FISH, qPCR or MLPA, and aCGH could be the next steps. It is noteworthy that rare MMSs will not be identified by any method other than array CGH due to the small size of the anomaly.</p>
<p>New techniques such as high throughput and fast next-generation sequencing (NGS) of whole genomes will produce much more data and will detect variations that will be difficult to interpret, which could be the highest limitation. Also, NGS will have limitations such as detection of copy numbers, low resolution in repetitive regions, and findings that need to be verified in the patient and also in the parent samples by aCGH, FISH, qPCR, MLPA, and even conventional cytogenetics. Overall, the older approaches like the aforementioned should not be neglected, as they have at least two important advantages: (1) in most cases results are relatively easy to interpret due to long-standing experience, and (2) large financial resources are not needed for their implementation.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The authors declared no potential conflicts of interest with respect to the authorship and publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Supported in parts by the BMBF/DLR BRA 09/020 and BLR 10/006, and the Else Kröner-Fresenius-Stiftung 2011_A42.</p>
</fn>
<fn fn-type="supplementary-material">
<p>Supplementary material for this article is available on the <italic>Journal of Histochemistry &amp; Cytochemistry</italic> Web site at <ext-link ext-link-type="uri" xlink:href="http://jhc.sagepub.com/supplemental">http://jhc.sagepub.com/supplemental</ext-link>.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alesi</surname><given-names>V</given-names></name>
<name><surname>Barrano</surname><given-names>G</given-names></name>
<name><surname>Morara</surname><given-names>S</given-names></name>
<name><surname>Darelli</surname><given-names>D</given-names></name>
<name><surname>Petrilli</surname><given-names>K</given-names></name>
<name><surname>Capalbo</surname><given-names>A</given-names></name>
<name><surname>Pacella</surname><given-names>M</given-names></name>
<name><surname>Haass</surname><given-names>C</given-names></name>
<name><surname>Finocchi</surname><given-names>M</given-names></name>
<name><surname>Novelli</surname><given-names>A</given-names></name><etal/>
</person-group>. <year>2011</year>. <article-title>A previously undescribed de novo 4p15 deletion in a patient with apparently isolated metopic craniosynostosis</article-title>. <source>Am J Med Genet</source>. <volume>5</volume>:<fpage>2543</fpage>–<lpage>2551</lpage>.</citation>
</ref>
<ref id="bibr2-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bailey</surname><given-names>JA</given-names></name>
<name><surname>Eichler</surname><given-names>EE</given-names></name>
</person-group>. <year>2006</year>. <article-title>Primate segmental duplications: crucibles of evolution, diversity and disease</article-title>. <source>Nat Rev Genet</source>. <volume>7</volume>:<fpage>552</fpage>–<lpage>564</lpage>.</citation>
</ref>
<ref id="bibr3-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Béna</surname><given-names>F</given-names></name>
<name><surname>Gimelli</surname><given-names>S</given-names></name>
<name><surname>Migliavacca</surname><given-names>E</given-names></name>
<name><surname>Brun-Druc</surname><given-names>N</given-names></name>
<name><surname>Buiting</surname><given-names>K</given-names></name>
<name><surname>Antonarakis</surname><given-names>SE</given-names></name>
<name><surname>Sharp</surname><given-names>AJ</given-names></name>
</person-group>. <year>2010</year>. <article-title>A recurrent 14q32.2 microdeletion mediated by expanded TGG repeats</article-title>. <source>Hum Mol Genet</source>. <volume>19</volume>:<fpage>1967</fpage>–<lpage>1973</lpage>.</citation>
</ref>
<ref id="bibr4-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bhatt</surname><given-names>S</given-names></name>
<name><surname>Moradkhani</surname><given-names>K</given-names></name>
<name><surname>Mrasek</surname><given-names>K</given-names></name>
<name><surname>Puechberty</surname><given-names>J</given-names></name>
<name><surname>Manvelyan</surname><given-names>M</given-names></name>
<name><surname>Hunstig</surname><given-names>F</given-names></name>
<name><surname>Lefort</surname><given-names>G</given-names></name>
<name><surname>Weise</surname><given-names>A</given-names></name>
<name><surname>Lespinasse</surname><given-names>J</given-names></name>
<name><surname>Sarda</surname><given-names>P</given-names></name><etal/>
</person-group>. <year>2009</year>. <article-title>Breakpoint mapping and complete analysis of meiotic segregation patterns in three men heterozygous for paracentric inversions</article-title>. <source>Eur J Hum Genet</source>. <volume>17</volume>:<fpage>44</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr5-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gazave</surname><given-names>E</given-names></name>
<name><surname>Darré</surname><given-names>F</given-names></name>
<name><surname>Morcillo-Suarez</surname><given-names>C</given-names></name>
<name><surname>Petit-Marty</surname><given-names>N</given-names></name>
<name><surname>Carreño</surname><given-names>A</given-names></name>
<name><surname>Marigorta</surname><given-names>UM</given-names></name>
<name><surname>Ryder</surname><given-names>OA</given-names></name>
<name><surname>Blancher</surname><given-names>A</given-names></name>
<name><surname>Rocchi</surname><given-names>M</given-names></name>
<name><surname>Bosch</surname><given-names>E</given-names></name><etal/>
</person-group>. <year>2011</year>. <article-title>Copy number variation analysis in the great apes reveals species-specific patterns of structural variation</article-title>. <source>Genome Res</source>. <volume>21</volume>:<fpage>1626</fpage>–<lpage>1639</lpage>.</citation>
</ref>
<ref id="bibr6-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gimelli</surname><given-names>G</given-names></name>
<name><surname>Pujana</surname><given-names>MA</given-names></name>
<name><surname>Patricelli</surname><given-names>MG</given-names></name>
<name><surname>Russo</surname><given-names>S</given-names></name>
<name><surname>Giardino</surname><given-names>D</given-names></name>
<name><surname>Larizza</surname><given-names>L</given-names></name>
<name><surname>Cheung</surname><given-names>J</given-names></name>
<name><surname>Armengol</surname><given-names>L</given-names></name>
<name><surname>Schinzel</surname><given-names>A</given-names></name>
<name><surname>Estivill</surname><given-names>X</given-names></name><etal/>
</person-group>. <year>2003</year>. <article-title>Genomic inversions of human chromosome 15q11-q13 in mothers of Angelman syndrome patients with class II (BP2/3) deletions</article-title>. <source>Hum Mol Genet</source>. <volume>12</volume>:<fpage>849</fpage>–<lpage>858</lpage>.</citation>
</ref>
<ref id="bibr7-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gu</surname><given-names>W</given-names></name>
<name><surname>Zhang</surname><given-names>F</given-names></name>
<name><surname>Lupski</surname><given-names>JR</given-names></name>
</person-group>. <year>2008</year>. <article-title>Mechanisms for human genomic rearrangements</article-title>. <source>Pathogenetics</source>. <volume>1</volume>:<fpage>4</fpage>.</citation>
</ref>
<ref id="bibr8-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jehee</surname><given-names>FS</given-names></name>
<name><surname>Takamori</surname><given-names>JT</given-names></name>
<name><surname>Medeiros</surname><given-names>PF</given-names></name>
<name><surname>Pordeus</surname><given-names>AC</given-names></name>
<name><surname>Latini</surname><given-names>FR</given-names></name>
<name><surname>Bertola</surname><given-names>DR</given-names></name>
<name><surname>Kim</surname><given-names>CA</given-names></name>
<name><surname>Passos-Bueno</surname><given-names>MR</given-names></name>
</person-group>. <year>2011</year>. <article-title>Using a combination of MLPA kits to detect chromosomal imbalances in patients with multiple congenital anomalies and mental retardation is a valuable choice for developing countries</article-title>. <source>Eur J Med Genet</source>. <volume>54</volume>:<fpage>425</fpage>–<lpage>432</lpage>.</citation>
</ref>
<ref id="bibr9-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kallioniemi</surname><given-names>A</given-names></name>
<name><surname>Kallioniemi</surname><given-names>OP</given-names></name>
<name><surname>Sudar</surname><given-names>D</given-names></name>
<name><surname>Rutovitz</surname><given-names>D</given-names></name>
<name><surname>Gray</surname><given-names>JW</given-names></name>
<name><surname>Waldman</surname><given-names>F</given-names></name>
<name><surname>Pinkel</surname><given-names>D.</given-names></name>
</person-group> <year>1992</year>. <article-title>Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors</article-title>. <source>Science</source>. <volume>258</volume>:<fpage>818</fpage>–<lpage>821</lpage>.</citation>
</ref>
<ref id="bibr10-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kidd</surname><given-names>JM</given-names></name>
<name><surname>Cooper</surname><given-names>GM</given-names></name>
<name><surname>Donahue</surname><given-names>WF</given-names></name>
<name><surname>Hayden</surname><given-names>HS</given-names></name>
<name><surname>Sampas</surname><given-names>N</given-names></name>
<name><surname>Graves</surname><given-names>T</given-names></name>
<name><surname>Hansen</surname><given-names>N</given-names></name>
<name><surname>Teague</surname><given-names>B</given-names></name>
<name><surname>Alkan</surname><given-names>C</given-names></name>
<name><surname>Antonacci</surname><given-names>F</given-names></name><etal/>
</person-group>. <year>2008</year>. <article-title>Mapping and sequencing of structural variation from eight human genomes</article-title>. <source>Nature</source>. <volume>453</volume>:<fpage>56</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr11-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koolen</surname><given-names>DA</given-names></name>
<name><surname>Vissers</surname><given-names>LE</given-names></name>
<name><surname>Pfundt</surname><given-names>R</given-names></name>
<name><surname>de Leeuw</surname><given-names>N</given-names></name>
<name><surname>Knight</surname><given-names>SJ</given-names></name>
<name><surname>Regan</surname><given-names>R</given-names></name>
<name><surname>Kooy</surname><given-names>RF</given-names></name>
<name><surname>Reyniers</surname><given-names>E</given-names></name>
<name><surname>Romano</surname><given-names>C</given-names></name>
<name><surname>Fichera</surname><given-names>M</given-names></name><etal/>
</person-group>. <year>2006</year>. <article-title>A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism</article-title>. <source>Nat Genet</source>. <volume>38</volume>:<fpage>999</fpage>–<lpage>1001</lpage>.</citation>
</ref>
<ref id="bibr12-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Korbel</surname><given-names>JO</given-names></name>
<name><surname>Urban</surname><given-names>AE</given-names></name>
<name><surname>Affourtit</surname><given-names>JP</given-names></name>
<name><surname>Godwin</surname><given-names>B</given-names></name>
<name><surname>Grubert</surname><given-names>F</given-names></name>
<name><surname>Simons</surname><given-names>JF</given-names></name>
<name><surname>Kim</surname><given-names>PM</given-names></name>
<name><surname>Palejev</surname><given-names>D</given-names></name>
<name><surname>Carriero</surname><given-names>NJ</given-names></name>
<name><surname>Du</surname><given-names>L</given-names></name><etal/>
</person-group>. <year>2007</year>. <article-title>Paired-end mapping reveals extensive structural variation in the human genome</article-title>. <source>Science</source>. <volume>318</volume>:<fpage>420</fpage>–<lpage>426</lpage>.</citation>
</ref>
<ref id="bibr13-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>C</given-names></name>
<name><surname>Iafrate</surname><given-names>AJ</given-names></name>
<name><surname>Brothman</surname><given-names>AR</given-names></name>
</person-group>. <year>2007</year>. <article-title>Copy number variations and clinical cytogenetic diagnosis of constitutional disorders</article-title>. <source>Nat Genet</source>. <volume>39</volume>:<fpage>48</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr14-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>JA</given-names></name>
<name><surname>Carvalho</surname><given-names>CM</given-names></name>
<name><surname>Lupski</surname><given-names>JR</given-names></name>
</person-group>. <year>2007</year>. <article-title>A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders</article-title>. <source>Cell</source>. <volume>131</volume>:<fpage>1235</fpage>–<lpage>1247</lpage>.</citation>
</ref>
<ref id="bibr15-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lieber</surname><given-names>MR</given-names></name>
</person-group>. <year>2008</year>. <article-title>The mechanism of human nonhomologous DNA end joining</article-title>. <source>J Biol Chem</source>. <volume>283</volume>:<fpage>1</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr16-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liehr</surname><given-names>T</given-names></name>
<name><surname>Ewers</surname><given-names>E</given-names></name>
<name><surname>Hamid</surname><given-names>AB</given-names></name>
<name><surname>Kosyakova</surname><given-names>N</given-names></name>
<name><surname>Voigt</surname><given-names>M</given-names></name>
<name><surname>Weise</surname><given-names>A</given-names></name>
<name><surname>Manvelyan</surname><given-names>M.</given-names></name>
</person-group> <year>2011</year>. <article-title>Small supernumerary marker chromosomes and uniparental disomy have a story to tell</article-title>. <source>J Histochem Cytochem</source>. <volume>59</volume>:<fpage>842</fpage>–<lpage>848</lpage>.</citation>
</ref>
<ref id="bibr17-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liehr</surname><given-names>T</given-names></name>
<name><surname>Grehl</surname><given-names>H</given-names></name>
<name><surname>Rautenstrauss</surname><given-names>B.</given-names></name>
</person-group> <year>1997</year>. <article-title>Molecular diagnosis of PMP22-associated neuropathies using fluorescence in situ hybridization (FISH) on archival peripheral nerve tissue preparations</article-title>. <source>Acta Neuropathol</source>. <volume>94</volume>:<fpage>266</fpage>–<lpage>271</lpage>.</citation>
</ref>
<ref id="bibr18-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lupski</surname><given-names>JR</given-names></name>
</person-group>. <year>1999</year>. <article-title>Charcot-Marie-Tooth polyneuropathy: duplication, gene dosage, and genetic heterogeneity</article-title>. <source>Pediatr Res</source>. <volume>45</volume>:<fpage>159</fpage>–<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr19-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marques-Bonet</surname><given-names>T</given-names></name>
<name><surname>Eichler</surname><given-names>EE</given-names></name>
</person-group>. <year>2009</year>. <article-title>The evolution of human segmental duplications and the core duplication hypothesis</article-title>. <source>Cold Spring Harb Symp Quant Biol</source>. <volume>74</volume>:<fpage>355</fpage>–<lpage>362</lpage>.</citation>
</ref>
<ref id="bibr20-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mkrtchyan</surname><given-names>H</given-names></name>
<name><surname>Gross</surname><given-names>M</given-names></name>
<name><surname>Hinreiner</surname><given-names>S</given-names></name>
<name><surname>Polytiko</surname><given-names>A</given-names></name>
<name><surname>Manvelyan</surname><given-names>M</given-names></name>
<name><surname>Mrasek</surname><given-names>K</given-names></name>
<name><surname>Kosyakova</surname><given-names>N</given-names></name>
<name><surname>Ewers</surname><given-names>E</given-names></name>
<name><surname>Nelle</surname><given-names>H</given-names></name>
<name><surname>Liehr</surname><given-names>T</given-names></name><etal/>
</person-group>. <year>2010</year>. <article-title>Early embryonic chromosome instability results in stable mosaic pattern in human tissues</article-title>. <source>PLoS One</source>. <volume>5</volume>:<fpage>9591</fpage>.</citation>
</ref>
<ref id="bibr21-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mrasek</surname><given-names>K</given-names></name>
<name><surname>Schoder</surname><given-names>C</given-names></name>
<name><surname>Teichmann</surname><given-names>AC</given-names></name>
<name><surname>Behr</surname><given-names>K</given-names></name>
<name><surname>Franze</surname><given-names>B</given-names></name>
<name><surname>Wilhelm</surname><given-names>K</given-names></name>
<name><surname>Blaurock</surname><given-names>N</given-names></name>
<name><surname>Claussen</surname><given-names>U</given-names></name>
<name><surname>Liehr</surname><given-names>T</given-names></name>
<name><surname>Weise</surname><given-names>A.</given-names></name>
</person-group> <year>2010</year>. <article-title>Global screening and extended nomenclature for 230 aphidicolin-inducible fragile sites, including 61 yet unreported ones</article-title>. <source>Int J Oncol</source>. <volume>36</volume>:<fpage>929</fpage>–<lpage>940</lpage>.</citation>
</ref>
<ref id="bibr22-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pinkel</surname><given-names>D</given-names></name>
<name><surname>Segraves</surname><given-names>R</given-names></name>
<name><surname>Sudar</surname><given-names>D</given-names></name>
<name><surname>Clark</surname><given-names>S</given-names></name>
<name><surname>Poole</surname><given-names>I</given-names></name>
<name><surname>Kowbel</surname><given-names>D</given-names></name>
<name><surname>Collins</surname><given-names>C</given-names></name>
<name><surname>Kuo</surname><given-names>WL</given-names></name>
<name><surname>Chen</surname><given-names>C</given-names></name>
<name><surname>Zhai</surname><given-names>Y</given-names></name><etal/>
</person-group>. <year>1998</year>. <article-title>High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays</article-title>. <source>Nat Genet</source>. <volume>20</volume>:<fpage>207</fpage>–<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr23-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schwartz</surname><given-names>M</given-names></name>
<name><surname>Zlotorynski</surname><given-names>E</given-names></name>
<name><surname>Goldberg</surname><given-names>M</given-names></name>
<name><surname>Ozeri</surname><given-names>E</given-names></name>
<name><surname>Rahat</surname><given-names>A</given-names></name>
<name><surname>le Sage</surname><given-names>C</given-names></name>
<name><surname>Chen</surname><given-names>BP</given-names></name>
<name><surname>Chen</surname><given-names>DJ</given-names></name>
<name><surname>Agami</surname><given-names>R</given-names></name>
<name><surname>Kerem</surname><given-names>B.</given-names></name>
</person-group> <year>2005</year>. <article-title>Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability</article-title>. <source>Genes Dev</source>. <volume>19</volume>:<fpage>2715</fpage>–<lpage>2726</lpage>.</citation>
</ref>
<ref id="bibr24-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shaffer</surname><given-names>LG</given-names></name>
</person-group>. <year>2001</year>. <article-title>Diagnosis of microdeletion syndromes by fluorescence in situ hybridization (FISH)</article-title>. <source>Curr Protoc Hum Genet</source>. <comment>Chapter 8: Unit</comment> <volume>8</volume>.<fpage>10</fpage>.</citation>
</ref>
<ref id="bibr25-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stankiewicz</surname><given-names>P</given-names></name>
<name><surname>Lupski</surname><given-names>JR</given-names></name>
</person-group>. <year>2002</year>. <article-title>Genome architecture, rearrangements and genomic disorders</article-title>. <source>Trends Genet</source>. <volume>18</volume>:<fpage>74</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr26-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sudmant</surname><given-names>PH</given-names></name>
<name><surname>Kitzman</surname><given-names>JO</given-names></name>
<name><surname>Antonacci</surname><given-names>F</given-names></name>
<name><surname>Alkan</surname><given-names>C</given-names></name>
<name><surname>Malig</surname><given-names>M</given-names></name>
<name><surname>Tsalenko</surname><given-names>A</given-names></name>
<name><surname>Sampas</surname><given-names>N</given-names></name>
<name><surname>Bruhn</surname><given-names>L</given-names></name>
<name><surname>Shendure</surname><given-names>J</given-names></name>
</person-group>; <collab>1000 Genomes Project</collab>, <person-group person-group-type="author">
<name><surname>Eichler</surname><given-names>EE</given-names></name>
</person-group>. <year>2010</year>. <article-title>Diversity of human copy number variation and multicopy genes</article-title>. <source>Science</source>. <volume>330</volume>:<fpage>641</fpage>–<lpage>646</lpage>.</citation>
</ref>
<ref id="bibr27-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Turner</surname><given-names>DJ</given-names></name>
<name><surname>Miretti</surname><given-names>M</given-names></name>
<name><surname>Rajan</surname><given-names>D</given-names></name>
<name><surname>Fiegler</surname><given-names>H</given-names></name>
<name><surname>Carter</surname><given-names>NP</given-names></name>
<name><surname>Blayney</surname><given-names>ML</given-names></name>
<name><surname>Beck</surname><given-names>S</given-names></name>
<name><surname>Hurles</surname><given-names>ME</given-names></name>
</person-group>. <year>2008</year>. <article-title>Germline rates of de novo meiotic deletions and duplications causing several genomic disorders</article-title>. <source>Nat Genet</source>. <volume>40</volume>:<fpage>90</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr28-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weise</surname><given-names>A</given-names></name>
<name><surname>Gross</surname><given-names>M</given-names></name>
<name><surname>Mrasek</surname><given-names>K</given-names></name>
<name><surname>Mkrtchyan</surname><given-names>H</given-names></name>
<name><surname>Horsthemke</surname><given-names>B</given-names></name>
<name><surname>Jonsrud</surname><given-names>C</given-names></name>
<name><surname>Von Eggeling</surname><given-names>F</given-names></name>
<name><surname>Hinreiner</surname><given-names>S</given-names></name>
<name><surname>Witthuhn</surname><given-names>V</given-names></name>
<name><surname>Claussen</surname><given-names>U</given-names></name><etal/>
</person-group>. <year>2008</year>. <article-title>Parental-origin-determination fluorescence in situ hybridization distinguishes homologous human chromosomes on a single-cell level</article-title>. <source>Int J Mol Med</source>. <volume>21</volume>:<fpage>189</fpage>–<lpage>200</lpage>.</citation>
</ref>
<ref id="bibr29-0022155412440001">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Weise</surname><given-names>A</given-names></name>
<name><surname>Mrasek</surname><given-names>K</given-names></name>
<name><surname>Kosyakova</surname><given-names>N</given-names></name>
<name><surname>Mkrtchyan</surname><given-names>H</given-names></name>
<name><surname>Gross</surname><given-names>M</given-names></name>
<name><surname>Klaschka</surname><given-names>V.</given-names></name>
</person-group> <year>2009</year>. <article-title>Fluorescence in situ hybridization (FISH)—application guide</article-title>. In: <person-group person-group-type="editor">
<name><surname>Liehr</surname><given-names>T</given-names></name>
</person-group>, editor. <source>ISH probes derived from BACs, including microwave treatment for better FISH</source>. <publisher-loc>Berlin Heidelberg, Germany</publisher-loc>: <publisher-name>Springer-Verlag</publisher-name>. <comment>Chapter 4</comment>.</citation>
</ref>
<ref id="bibr30-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weksberg</surname><given-names>R</given-names></name>
<name><surname>Hughes</surname><given-names>S</given-names></name>
<name><surname>Moldovan</surname><given-names>L</given-names></name>
<name><surname>Bassett</surname><given-names>AS</given-names></name>
<name><surname>Chow</surname><given-names>EW</given-names></name>
<name><surname>Squire</surname><given-names>JA</given-names></name>
</person-group>. <year>2005</year>. <article-title>A method for accurate detection of genomic microdeletions using real-time quantitative PCR</article-title>. <source>BMC Genomics</source>. <volume>6</volume>:<fpage>180</fpage>.</citation>
</ref>
<ref id="bibr31-0022155412440001">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Willatt</surname><given-names>L</given-names></name>
<name><surname>Cox</surname><given-names>J</given-names></name>
<name><surname>Barber</surname><given-names>J</given-names></name>
<name><surname>Cabanas</surname><given-names>ED</given-names></name>
<name><surname>Collins</surname><given-names>A</given-names></name>
<name><surname>Donnai</surname><given-names>D</given-names></name>
<name><surname>FitzPatrick</surname><given-names>DR</given-names></name>
<name><surname>Maher</surname><given-names>E</given-names></name>
<name><surname>Martin</surname><given-names>H</given-names></name>
<name><surname>Parnau</surname><given-names>J</given-names></name><etal/>
</person-group>. <year>2005</year>. <article-title>3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome</article-title>. <source>Am J Hum Genet</source>. <volume>77</volume>:<fpage>154</fpage>–<lpage>160</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>